Skip to main content

MYX 643 (Tamoxifen Citrate 20 mg)

Pill with imprint MYX 643 is White, Round and has been identified as Tamoxifen Citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, male; breast cancer, metastatic; breast cancer; breast cancer, adjuvant; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYX 643

Tamoxifen Citrate

Imprint
MYX 643
Strength
20 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Manufacturer
Mayne Pharma
National Drug Code (NDC)
51862-0643
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, hypromellose 2910 (5 mPa.s), polyethylene glycol 400, povidone k30, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.